Drug Shortage Report for CHOLESTYRAMINE-ODAN

Last updated on 2020-04-13 History
Report ID 106728
Drug Identification Number 02455609
Brand name CHOLESTYRAMINE-ODAN
Common or Proper name Cholestyramine for Oral Suspension, USP
Company Name ODAN LABORATORIES LTD
Market Status MARKETED
Active Ingredient(s) CHOLESTYRAMINE RESIN
Strength(s) 4G
Dosage form(s) POWDER FOR SUSPENSION
Route of administration ORAL
Packaging size 30 x 4g
ATC code C10AC
ATC description LIPID MODIFYING AGENTS, PLAIN
Reason for shortage Delay in shipping of the drug.
Anticipated start date
Actual start date 2020-02-19
Estimated end date 2020-04-27
Actual end date 2020-04-09
Shortage status Resolved
Updated date 2020-04-13
Company comments
Health Canada comments
Company contact information info@odanlab.com Tel.: 1-800-387-9342 Fax: 1-800-329-6326

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v9 2020-04-13 French Compare
v8 2020-04-13 English Compare
v7 2020-03-19 French Compare
v6 2020-03-19 English Compare
v5 2020-03-19 English Compare
v4 2020-03-19 English Compare
v3 2020-02-20 English Compare
v2 2020-02-19 French Compare
v1 2020-02-19 English Compare